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Supplementary Note 1. 
Stage 1: Finding human α-helical transmembrane domains 
The consensus human membrane proteome was previously predicted by using 
different transmembrane α-helix prediction methods3-8, including TMHMM 2.01 
(http://proteinatlas.org)2. However, the assembly of the human genome 
(ENSEMBL 36.52) has been updated since these studies were performed. 
Because our goal is to provide the basis for a dynamical up-to-date assessment, 
reflecting new membrane protein structures as they are determined, we used 
TMHMM 2.0 to identify transmembrane spanning proteins in an updated RefSeq 
version (BUILD 37.2) of the human genome9. For robustness of membrane 
protein identification, alignment, and clustering, only membrane proteins that are 
predicted to have at least two transmembrane α-helices were included in the 
analysis. For each full-length sequence, only the transmembrane domain from 
the first to the last predicted transmembrane α-helix residue was used for all 
subsequent analyses. To remove highly similar sequences from our analysis, the 
resulting domain set was clustered at 98% sequence identity (USEARCH10) 
followed by retaining only one representative for each cluster. 
Stage 2: Assessing current modeling coverage 
All transmembrane domain sequences were attempted to be modeled using 
ModPipe11-13, which relies on PSI-BLAST14 and MODELLER15 for its functionality. 
Sequence-structure matches were established using fold assignment methods, 
including sequence-sequence16, profile-sequences14,17, and profile-profile17,18 
alignments, using a PDB19 template database from 9/30/2011. The probability of 
finding a template structure was increased by using alignments with the E-value 
threshold of 1.0. By default, ten models were calculated for each alignment. A 
representative model for each alignment was then chosen by ranking based on 
the atomic distance-dependent statistical potential DOPE20.  
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Finally, the fold of each comparative model was evaluated using several quality 
scores, using an approach originally developed for globular protein structures12. 
A comparative protein structure model was considered ‘reliable’ if it scored better 
than certain threshold for at least one of the quality criteria (zDOPE20 < 0, 
MPQS12 > 1.0, GA34121 > 0.7, TSVMod22 native overlap > 0.4, target-template 
sequence identity > 30%) or was generated from a significant sequence-structure 
alignment (an alignment is considered significant, if the corresponding E-value is 
lower than 0.0001)12; reliable models are generally predicted to have the correct 
fold. The reliable models were deposited in the ModBase database of modeled 
structures (salilab.org/modbase/search?dataset=tmh_sequences). They provide 
a useful resource for investigating a membrane protein whose structure has not 
yet been determined by experiment. 
The ‘modeling coverage’ was calculated for each modeled domain sequence, 
taking into account all reliable models produced by ModPipe, as follows. Each 
residue in the sequence was first annotated with the sequence identity between 
the modeled sequence and its closest template. The modeling coverage was 
then computed as the percentage of residues above a given sequence identity 
threshold. We also classified the modeling coverage of a sequence as ‘high’ (> 
90% of domain residues are modeled), ‘medium’ (60-90%), and low (<60%). 
Stage 3: Clustering of domain sequences 
For assistance in target selection, transmembrane domain sequences were 
clustered into the smallest possible number of clusters, such that the structure of 
any member of a cluster allows for comparative modeling of the remaining cluster 
members at specified thresholds on target-template sequence identity and 
fraction of aligned residues (coverage)23. To obtain a pragmatic solution, we 
clustered the human domain sequences using BLASTCLUST24 at several 
sequence identity (20%, 25%, 30%) and coverage (50%, 70%, 90%) thresholds. 
The BLASTCLUST algorithm includes in a cluster all domains that match at least 
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one cluster domain at the specified sequence identity and coverage thresholds. A 
domain can only be a member of one cluster. As an aside, we also tested 
another algorithm, USEARCH10, but the corresponding clusters were judged to 
be less suitable for the purposes of structural genomics (data not shown). 
Stage 4: Assessing target selection strategies 
We tested two target selection strategies, ‘guided’ and ‘random.’ These 
strategies were assessed with respect to how many target structures need to be 
determined by experiment to achieve varying degrees of structural 
characterization of the human membrane proteome by comparative modeling. 
Guided target selection prioritizes experimental structure determination of 
domains by the size of the clusters that they make accessible to modeling. In 
contrast, random target selection picks targets randomly from a list of domain 
sequences without known structures. In addition, the utility of the existing target 
lists of the nine PSI membrane protein centers (TargetDB25; October 2011) for 
modeling the human membrane proteome was computed; these targets were 
matched to the human α-helical transmembrane domains by pairwise sequence 
comparison using BLASTP14. 
Stage 5: Expanding the target set by adding homologous sequences 
The cluster analysis was focused on the human sequences only, in the 
expectation that each human cluster will have a large number of non-human 
sequences related to at least one human member at more than 30% sequence 
identity. To get these non-human homologs, a multiple sequence profile of each 
human domain sequence was prepared by scanning the sequence against all 
18.5 million sequences in the UniProt database (release-2011_08) using the 
BUILD_PROFILE module of MODELLER18, as implemented in ModPipe 
(http://salilab.org/modpipe), first using the default settings (E-value: 0.1, five 
iterations) against a non-redundant (at the 90% sequence identity level) version 
of UniProt. The profiles were then expanded by one additional iteration using the 
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full UniProt database. Once the profile was calculated, only homologs with the 
sequence identity of at least 30% were retained. The set of such homologs for all 
human domains in the cluster corresponds to potential structural genomics 
targets that allow modeling of any cluster member. 
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Supplementary Note 2.  
Stage 1: Finding human α-helical transmembrane domains 
Of the 29,375 unique human protein sequences from the RefSeq-37 database of 
the human genome9, 7,299 were predicted by the TMHMM 2.01 program to 
contain at least one transmembrane α-helix; 3,838 were predicted to contain two 
or more such helices. For each full-length sequence, only the transmembrane 
domain from the first to the last predicted transmembrane α-helix residue was 
used for all subsequent analyses. Only a single representative of sequences with 
more than 98% sequence identity to each other was retained, using program 
USEARCH10, yielding the final non-redundant dataset of 2,925 domains (Suppl. 
Fig. 1a). 
Stage 2: Assessing current modeling coverage 
To provide context for assessing various target selection lists and strategies, we 
assessed the current ability to model each of the human α-helical 
transmembrane domain sequences. Automated comparative modeling using 
ModPipe12 resulted in “reliable” models (Supp. Note 1) for 10-100% of residues in 
2,683 of the 2,925 non-redundant human α-helical transmembrane domains. The 
modeling coverage of a domain sequence was calculated as the percentage of 
its residues that were modeled based on a template structure with the sequence 
identity to the modeled sequence above a given sequence identity threshold 
(Suppl. Fig. 1b). The modeling coverage was described as high, medium, and 
low when >90%, 60-90%, and < 60% of the domain residues, respectively, were 
modeled. 
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Stage 3: Clustering of domain sequences 
A cluster suitable for structural genomics target selection needs to satisfy two 
requirements to ensure that a structure determined for one of its members allows 
the modeling of most if not all other cluster members: (i) member sequences 
must be sufficiently similar to each other and (ii) member sequences must be 
aligned without long gaps. Simultaneously, the number of clusters of a given set 
of sequences, such as the human membrane proteome, needs to be minimized, 
to maximize the efficiency of the structural genomics effort. 
To find the optimal clustering parameters, the domain sequences were clustered 
based on threshold levels of proportion of residues that can be aligned (>50%, 
>70%, and >90%; “coverage threshold”) and the sequence identity of the aligned 
segments (>20%, >25%, and >30%; “sequence identity threshold”), using 
program BLASTCLUST24 (Suppl. Table 1). For quality control, the sequences in 
each cluster were aligned, using a multiple sequence alignment program 
MUSCLE26. We quantified the gaps in an alignment by computing its “gap ratio”, 
defined as the proportion of single residue gap positions in the alignment. Hence, 
a small gap ratio is associated with more accurate alignments that are preferred 
for comparative modeling. At the same coverage threshold, the gap ratio is 
approximately constant for the three sequence identity thresholds. As expected, 
the gap ratio is highest and lowest at the coverage thresholds of 50% and 90%, 
respectively. For further analysis, the intermediary coverage threshold of 70% 
was chosen.  
Next, we inspected the number of members in a cluster (cluster size; Suppl. Fig. 
2a). The distribution of the number of clusters as a function of cluster size (eg, 
the red bars in Suppl. Fig. 2a) is similar at the three sequence identity thresholds. 
Approximately 100 of the clusters contain 4 or more members. One large cluster 
with approximately 600 members, including the GPCR families, occurs at all 
three sequence identity thresholds. Finally, we assessed the current average 
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modeling coverage of the sequences in each cluster (Suppl. Fig. 2b). Large 
clusters that currently have low average modeling coverage are attractive 
sources of targets for structural genomics, because their representative 
structures would result in a large increase in reliably modeled sequences. 
Stage 4: Assessing target selection strategies 
We assessed ‘guided’ and ‘random’ target selection strategies with respect to the 
number of target structures that need to be determined by experiment to achieve 
varying degrees of structural characterization of the human membrane proteome 
by comparative modeling. Guided target selection prioritizes experimental 
structure determination of targets by the size of the clusters that they make 
accessible to modeling. In contrast, random target selection picks targets 
randomly from a list of domain sequences without known structures. 
To compare and contrast the guided and random target selection schemes, we 
computed the number of domain sequences that can be modeled based on the 
future successful determination of a 100 new target structures, with a modeling 
coverage threshold of 70% at different sequence identity thresholds27. The 
number of 100 was selected because it is feasible for the nine PSI centers to 
determine 100 membrane protein structures during two five-year cycles of 
PSI:Biology. 
In the first scenario, we considered all unique human α-helical transmembrane 
domains, whether or not they can be currently modeled (Suppl. Fig. 3a; Suppl. 
Table 2). As expected, the guided target selection yields a significantly higher 
number of domain sequences covered when compared to the random target 
selection at the same sequence identity thresholds. For guided selection, the 
number of the domains that could be modeled based on 100 target structures is 
1,445, 1,488, and 1,514 at 30%, 25%, and 20% sequence identity threshold, 
respectively (at 70% modeling coverage threshold). In contrast, for the random 
selection, 100 structures would allow comparative modeling of only 
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approximately 900, 950, and 1,000 sequences at 30%, 25%, and 20% sequence 
identity threshold, respectively. This result highlights the superior efficiency of the 
guided target selection strategy over random choice27. Thus, the number of 
sequences that can be structurally characterized increases by approximately 
50% when using the guided target selection strategy, as proposed here, instead 
of the random selection strategy. 
In the second scenario, only sequences without current models were considered 
by first removing all clusters with sufficiently close homologs of known structure 
from the analysis (Suppl. Fig. 3b). As expected, guided target selection is also 
superior over random choice in this scenario. 
The current target lists of the nine PSI membrane protein centers collectively 
contain 14,591 unique targets (Suppl. Table 3a). Of these, we identified 464 
(3.2%) sequences that match human α-helical transmembrane domain 
sequences at high sequence identity (90%) and modeling coverage thresholds 
(90%, Suppl. Table 2). These sequences were then mapped onto the domain 
clusters, resulting in 57 clusters comprising a total of 1,190 sequences, which 
have at least one cluster member that is already included in the target lists of the 
nine PSI membrane protein centers. 20 of these clusters include sequences that 
have already been structurally characterized at the 25% sequence identity level, 
leaving a total of 47 clusters with 1,075 structurally uncharacterized sequences. 
Structure determination of at least one member from each one of these 47 
clusters would thus increase the structural coverage of the human α-helical 
transmembrane proteome by approximately 1,000. 
Stage 5: Expanding the target set by adding homologous sequences 
To augment the potential target pool by the non-human homologs of the human 
sequences, we identified approximately 450,000 non-human sequences from 
approximately 50,000 different organisms homologous to the human α-helical 
transmembrane domains over at least 70% of the residues at the 30% sequence 
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identity threshold. The corresponding expanded alignments can be valuable for 
target selection.  
On average, each domain sequence has approximately 2,000 homologs from 
other organisms in UniProt. The number of homologs per sequence ranges from 
approximately 50,000 for the transmembrane domain of cytochrome b to only 
one for 40 transmembrane domains (Suppl. Fig. 4). For 17 human domain 
sequences, scanning UniProt did not identify any non-human homologs given the 
two thresholds used. While the non-human homologs are, as expected, 
predominantly from eukaryotic organisms (368,401 sequences), we were also 
able to identify 82,386 sequences from bacteria and 1,985 sequences from 
archaea (Suppl. Fig. 4).  
Most of the larger clusters with a significant number of non-eukaryotic homologs 
have already been structurally characterized (e.g., ATPases and aquaporins). 
Clusters with bacterial and archaeal homologs with low modeling coverage 
include for example SLC transporters and lipid phosphate phosphatases. A full 
list of the sequences with non-eukaryotic homologs, cluster sizes, and 
annotations can be found at salilab.org/membrane, menu item ‘Non-human 
Homologs’.  
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Supplementary Note 3.  
Web-based knowledgebase.  
We created a dynamically updateable collaborative website 
(http://salilab.org/projects/membrane), using as content management system 
Drupal 7 (http://drupal.org). The website contains all predicted human α-helical 
transmembrane domain sequences, their UniProt28 annotations, links to the 
associated cluster alignments, and images that indicate the modeling coverage 
and the location of the predicted α-helical transmembrane domains. Human α-
helical transmembrane domains, the current PSI target list, and non-human 
homologs are linked. The results also provide clustering, comparative models 
when available, and a list of non-human homologous sequences. In addition, a 
visitor can leave comments or additions. Collaborators can edit and update the 
pages, as well as add pages summarizing their own data-mining efforts. These 
data and tools enable the PSI researchers to evaluate their current targets and 
potentially select additional targets, while maximizing their impact on the 
structural characterization of the human α-helical transmembrane proteome. 
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Supplementary Table 1. Number of domain clusters and the corresponding 
gap ratio at different sequence identity and coverage thresholds. 
Sequence	  identity	  
threshold	  
20%	   20%	   20%	   25%	   25%	   25%	   30%	   30%	   30%	  
Coverage	  threshold	   50%	   70%	   90%	   50%	   70%	   90%	   50%	   70%	   90%	  
Number	  of	  clusters	   1,059	   1,186	   1,394	   1,074	   1,201	   1,406	   1,106	   1,236	   1,435	  
Gap	  ratio	   11.3%	   8.2%	   5.5%	   10.9%	   8.0%	   5.4%	   10.4%	   7.7%	   5.4%	  
 
A small gap ratio is associated with more accurate alignments that are preferred 
for comparative modeling. For the current analysis, the gap ratio was computed 
for the alignments obtained at different sequence identity thresholds and 
coverage thresholds.  
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Supplementary Table 3: Target lists for 9 PSI membrane protein centers. 
a) Number of PSI targets that match human α-helical transmembrane domains. 
Center Total number 
of targets  
Number of targets that match transmembrane 
domains (% sequence identity / % residues aligned)  
  25/50 25/90 30/50 30/90 90/50 90/90 
        CSMPa 2,454 835 362 509 258 106 96 
GPCRb 127 127 126 127 126 127 125 
MPIDc 85 8 1 2 0 0 0 
MPSBCd 40 31 8 18 2 0 0 
MPSbyNMRe 12 6 6 5 4 4 4 
NYCOMPSf 12,881 4,840 1,599 2,859 1,041 232 218 
TEMIMPSg 89 30 18 26 17 9 8 
TMPCh 112 43 28 36 24 8 8 
TransportPDBi 586 563 549 561 535 510 499 
Total (unique 
sequences) 
14,591 6,264 2,600 4,003 1,942 965 928 
b) Number of human α-helical transmembrane domains that match PSI targets.  
Center Number of human α-helical transmembrane domains that 
match PSI targets (% sequence identity / % residues aligned) 
 25/50 25/90 30/50 30/90 90/50 90/90 CSMPa 1,581 892 1,016 613 104 96 
GPCRb 873 796 813 749 180 176 
MPIDc 12 1 2 0 0 0 
MPSBCd 96 11 28 4 0 0 
MPSbyNMRe 146 111 54 42 4 4 
NYCOMPSf 2,210 1,146 1,354 761 96 87 
TEMIMPSg 221 141 112 82 10 9 
TMPCh 374 281 201 142 10 10 
TransportPDBi 950 770 856 757 748 719 
Total (unique 
sequences) 
3,017 2,216 2,563 1,991 1,086 1,039 
aCenter for Structure of Membrane Proteins, bGPCR Network, cCenter for Membrane 
Proteins in Infectious Diseases, dMembrane Protein Structural Biology Consortium, 
eMembrane Protein Structures by Solution NMR, fNew York Consortium on Membrane 
Protein Structure, gTranscontinental EM Initiative for Membrane Protein Structure, 
hTransmembrane Protein Center, iCenter for the X-ray Structure Determination of 
Human Transporters. Suppl. Table 2a shows the actual PSI targets and their similarity to 
the closest human α-helical transmembrane domain(s). Suppl. Table 2b show how many 
human α-helical transmembrane domains are related to these targets. The PSI target 
sequences were retrieved from TargetTrack (Oct 2012), the structural biology target 
registration database (http://sbkb.org/tt/). 
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Supplementary Table 2.  Guided versus random target selection*. 
Trans 
membrane 
domains 
Sequence identity threshold (%) 20% 25% 30% 
Number of domains 2,925 2,925 2,925 
Number of domains without models 1,932 2,642 2,674 
Guided 
Target 
Selection  
Number of domains (100) 1,514 1,488 1,445 
Number of domains without models (100) 793 1,407 1,348 
Number of modeled domains (100) 1,786 1,690 1,599 
Random 
Target 
Selection 
Number of domains (100) 1,000 950 900 
Number of domains without models (100) 400 930 920 
Number of modeled domains (100) 1,037 1,213 1,171 
 
* The guided and random target selection strategies are assessed with respect to 
structural coverage. For both strategies, 100 target structures have been assumed 
(Stage 4) and the 70% coverage threshold was imposed. For guided (random) target 
selection: ‘Number of domains (100)’, the number of human α -helical transmembrane 
domains in the 100 largest (random) domain clusters. ‘Number of domains without 
models (100)’, the number of transmembrane domains in the 100 largest (random) 
domain clusters with low or medium model coverage. ‘Number of modeled domains 
(100)’, the number of modeled domains after determining the 100 target structures. The 
number of domains in the first 100 clusters increases when the clustering sequence 
identity threshold decreases from 30% to 25%, because the number of sequences per 
cluster increases. The number of domains without models decreases when the 
sequence identity threshold drops to 20%, because the sequences in the largest cluster 
(the GPCR sequences) become modeled. 
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Supplementary Figure 1. a) The number of sequences with a given number of 
predicted transmembrane α-helices in human transmembrane domains. The number of 
sequences with one predicted transmembrane α−helix is indicated by a hashed bar; 
these sequences have not been included in the subsequent analysis. b) Modeling the 
human α-helical transmembrane domain proteome based on currently known structures. 
The number of modeled domains is shown as a function of the modeling coverage 
threshold (percent sequence residues covered), for the sequence identity thresholds 
ranging from 20% to 100%. The number of domains that can be modeled increases with 
the lower sequence identity and lower model coverage thresholds.  
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Supplementary Figure 2. Clustering. a) Distributions of cluster sizes for 30%, 25%, 
and 20% sequence identity thresholds. The clusters of several superfamilies are 
indicated. b) The number of sequences and clusters for varied modeling coverage and 
sequence identity thresholds, used both for clustering and calculating the modeling 
coverage) at 70% coverage threshold for the clustering.  
Nature Structural & Molecular Biology: doi:10.1038/nsmb.2508
  
 
18 
 
 
Supplementary Figure 3. Target selection schemes. The number of sequences 
modeled is shown for six scenaria, corresponding to the random and guided target 
selections at three sequence identity thresholds. The plots on the right zoom into the 
plots on the left, for more detail. a) All clusters are considered, including those with 
homologs of already determined membrane protein structures. b) Already known 
membrane protein structures are taken into account by removing clusters with at least 
one sequence for which at least 90% of residues are modelable at the given sequence 
identity threshold. 
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Supplementary Figure 4. Expansion of human α-helical transmembrane 
domain clusters by their homologs from other species. The total number of 
human domain sequences (y-axis) with a given maximum number of non-human 
homologs (in bins) in UniProt is shown for homologous sequences from eukaryotes, 
bacteria, and archaea. For clarity, the x-axis is truncated (there are 745 sequences with 
up to 50,000 homologs from eukaryotes, 128 sequences with up to 7,000 homologs for 
bacteria, and 6 sequences with up to 126 homologs for archaea).  
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